The rising interest in GLP-1 agonists for diabetes has sparked a question about application forms : patches versus tablets . Traditionally , GLP-1 therapies were solely available in pill form, but the introduction of patches offers a different choice . Transdermal systems might be advantageous for individuals facing difficulty with oral medicati… Read More